Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

Abstract

The inhibition of VEGF-induced choroidal angiogenesis in vitro, and CNV in vivo by PPAR-gamma ligands suggests the potential application of these agents in the large group of patients with age-related macular degeneration complicated by CNV.